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Abstract
Background/Aims: The aim of this study was to analyze the effect of BMP2 on osteogenic 
differentiation of human adipose tissue-derived stromal cells (hADSCs). Methods: Cultured 
cells were differentiated into osteogenic lineage in the presence of BMP2. Gene expressions 
were determined by real time PCR. Results: BMP2 increased (2/8) or inhibited (6/8) osteogenic 
differentiation according to hADSCs batches. Regardless of the BMP2 action on osteogenic 
differentiation, BMP2 induced lipid droplet formation under an osteogenic differentiation 
condition in all batches of hADSCs, not hBMSCs, to be tested, which was confirmed by 
analysis of adipogenesis related genes expression. hADSCs expressed various BMP receptors. 
BMP2 increased expression of BMP2-responsive genes such as DLX3 and ID2, and induced 
SMAD1 phosphorylation in hADSCs and hBMSCs. BMP2 increased osteogenic differentiation 
of hADSCs in osteogenic medium in which dexamethasone was omitted. The addition of 
BMP2 in the control culture media containing dexamethasone alone lead to formation of 
lipid droplets and increased C/EBP-α expression in hADSCs. In the presence of TNF-α, BMP2 
stimulated osteogenic differentiation of hADSCs even in hADSCs batches in which treatment 
of BMP2 alone inhibited osteogenic differentiation. Conclusion: These data indicate that the 
control of osteogenesis and adipogenesis in hADSCs is closely related, and that hADSCs have 
preferential commitment to adipogenic lineages. 
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Introduction
Mesenchymal stem cells (MSCs) were first identified in bone marrow [1]. They can be 
expanded in culture while retaining their multipotency and can differentiate into a variety of 
cell types, including osteoblasts, chondrocytes, myocytes, and adipocytes [2, 3]. Therefore, 
the development of MSC-based techniques has become a major research objective in the 
field of tissue engineering, and provides a unique model for a better understanding of early 
differentiation events, as these cells are able to differentiate into multiple mesenchymal 
lineages. 
Recent studies show that several other tissues also contain MSCs. In 2001, Zuk et 
al. demonstrated that human adipose tissue contains multipotent stem cells that can 
differentiate along different lineages such as bone, cartilage, fat, and muscle [4]. Adipose 
tissue-derived stromal cells (ADSCs) share many of the characteristics of their counterparts 
in bone marrow, including extensive proliferative potential and the ability to differentiate 
into cells with adipogenic, osteogenic, chondrogenic, and myogenic lineages [5, 6]. There is 
strong evidence that ADSCs undergo rapid osteogenesis both in vitro and in vivo [7, 8]. 
The BMP family belongs to the transforming growth factor-beta (TGF-β) superfamily. 
The classical role for BMPs was considered to be induction of (ectopic) cartilage and bone 
formation [9], BMP2, BMP4, BMP6, and BMP7 are the most important cytokines in bone 
tissue engineering [10], as they play paramount roles in osteogenic differentiation of various 
MSCs [11, 12]. In contrast to bone marrow mesenchymal stem cells (BMSCs), the effect of 
BMP2 on osteogenic differentiation in hADSCs is not clearly defined. Zuk et al. reported that 
hADSCs have a defective BMP2 signaling pathway [13] and Cruz et al. showed that BMP2 
fails to enhance osteogenic differentiation of hADSCs [14]. However, Panetta et al. showed 
that BMP2 increases osteogenic differentiation in hADSCs [15]. BMP2 has been reported to 
increase in vivo bone formation by transplantation of hADSCs [16-18]. To develop optimal in 
vitro manipulation technique for enhancing in vivo bone regeneration of by transplantation 
of hADSCs, clear understanding about BMP2 actions on osteogenic differentiation of hADSCs 
is necessary. 
The present study was designed to clarify the effect of BMP2 on osteogenic differentiation 
of hADSCs and to determine the extent to which BMP2 and TNF-α alone and in combination 
alter hADSCs differentiation. The data showed that BMP2 induces lipid droplet formation 
even at osteogenic condition in the presence of dexamethasone in contrast with hBMSCs and 
that inhibition of this process enhances osteogenic differentiation of hADSCs.
Materials and Methods
Cell culture 
All protocols involving human subjects were approved by the Institutional Review Board of Pusan 
National University. After informed consent, superfluous materials were obtained from eight individuals 
undergoing total hip arthroplasty and elective abdominoplasty. hBMSCs and hADSCs were isolated and 
characterized according to the methods described in the previous studies [19, 20]. The isolated cells were 
cultured in Low-glucose DMEM with 10% fetal bovine serum, 100 μg/ml streptomycin and 100 mg/ml 
penicillin (CCM) in 5% CO2 environment at 37°C. Cells between third and fifth passages were used for 
experiments. 
Osteogenic and adipogenic differentiation 
After plating the cells on a 12-well plate (100,000 cells/well), they were grown to confluency. Then, 
osteogenic differentiation was induced by culturing the cells for 2–3 weeks in osteogenic induction medium 
(OIM ; 10% FBS, 0.1 μM dexamethasone, 10 mM β-glycerophosphate, and 250 μM ascorbic acid in L-DMEM) 
and the level of extracellular matrix calcification was examined by Alizarin Red S staining. In order to obtain 
quantitative data, 300 μl of 10% cetylpyridiniumchloride in 10 mM sodium phosphate (pH 7.0) was added 
to the stained culture dish. After 15 min, the extract was diluted 10 fold with 10% cetylpyridiniumchloride 
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in 10 mM sodium phosphate (pH 7.0), then the absorbance of the diluted extract was assayed by a 
spectrophotometer at 562 nm.
Adipogenic differentiation was induced by culturing MSCs for 10–14 days in adipogenic medium 
(AIM; 10% FBS, 1 μM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine, and 200 μM indomethacin in 
L-DMEM) and lipid droplets formation was visualized using Oil Red O stain as an indicator of intracellular 
lipid accumulation. 
Quantitation of mineral formation 
For the calcium deposition assay, cultures were washed twice with PBS. Mineral was then collected 
after dissolution with 300 ml of 0.5 N hydrocholoric acid at room temperature overnight and the samples 
assayed the following day. Incorporation of calcium in the extracellular matrix was quantified using a 
commercial diagnostic kit (QuantiChrom Calcium Assay Kit, DICA-500; Bio Assay Systems, Hayward, CA, 
USA), in accordance with the manufacturer’s instructions. Absorbance was compared with curves prepared 
using standard solutions of calcium. Calcium deposition was expressed as mM per well of tissue culture 
12-well plates.
Real-Time polymerase chain reaction (PCR)
Total RNA was extracted using Trizol (Invitrogen), according to the manufacturer’s instructions and 
reverse-transcribed into cDNA with the Reverse Transcriptase M-MLV (Promega, Madison, WI, USA). Real 
time PCR was performed using a Power SYBR Green PCR Master Mix on the ABI 7500 Instrument (Applied 
Biosystems, Warrington, UK). The primer sequences used in the experiment are listed in the Table1. For 
each primer pair, the linearity of detection was confirmed by measuring a dilution curve with cDNA isolated 
from hBMSCs or hADSCs. GUSB (Beta-D-glucuronidase) and β-actin were determined to be appropriate 
internal controls for hADSCs and hBMSCs, respectively. Because β-actin mRNA levels were changed during 
differentiation of hADSCs (unpublished data), GUSB mRNA, of which expression was maintained at a 
constant levels during differentiation, was used for an internal control in differentiated hADSCs. The data 
were presented as the relative abundance of the gene of interest to GUSB or β-actin.
Western blot analysis
Confluent hBMSCs and hADSCs were treated under the appropriate conditions and lysed, after which 
the protein content of the lysate was determined using a protein assay kit. The proteins were loaded on 
10% sodium dodecyl sulfate-polyacrylamide gels, transferred to nitrocellulose membranes (Hybond-ECL; 
Amersham Pharmacia Biotech, Piscataway, NJ, USA), and probed with monoclonal or polyclonal antibodies 
(anti-SMAD1, antiphospho (Ser463/465)-SMAD1 and anti β-actin; Cell Signaling Technology, Danvers, MA, 
Table 1. Sequences of real time PCR primers
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USA). Immunoreactive bands were detected with anti-rabbit peroxidase conjugated secondary antibodies 
and visualized via enhanced chemiluminescence.
Statistical analysis 
All results are presented as mean ± SEM. The data were analyzed using Student’s t-test when two 
groups were compare or by ANOVA for more than two groups. Post hoc range tests and pairwise multiple 
comparisons were conducted with Tukey adjustment to determine which means differ. Graphad Prism 6.0 
(GraphPad Software San Diego, CA, USA) was used for statistical analysis. Probability values of P < 0.05 were 
considered statistically significant.
Results
Effect of BMP2 on osteogenic differentiation of hADSCs
We first determined the effect of BMP2 on osteogenic differentiation of hADSCs and 
hBMSCs. Adding BMP2 increased osteogenic differentiation of hBMSCs in a dose-dependent 
manner (Fig. 1A and B). In contrast, the response to BMP2 in hADSCs vary according to 
cell donors. Although the addition of BMP2 increased osteogenic differentiation in hADSCs 
isolated from 2 donors among 8 donors to be examined in this experiment donors, in hADSCs 
isolated from 6 donors (6/8) the addition of BMP2 inhibited osteogenic differentiation (Fig. 
2A). Oil Red O staining of hADSCs treated with BMP2 revealed that adding BMP2 increased 
the formation of lipid droplets in hADSCs in all batches to be tested in this experiment 
regardless of the BMP2 response in osteogenic differentiation (Fig. 2B). In the following 
experiments, hADSCs in which BMP2 inhibited osteogenic differentiation were used.
Fig. 1. The treatment of 
BMP2 enhances osteo-
genic differentiation of 
hBMSCs. (A) hBMSCs were 
grown to confluence, and 
then osteogenic differenti-
ation was induced by OIM 
without or with BMP2. 
Osteogenic differentiation 
was determined by Aliza-
rin Red S staining to visu-
alize calcification deposits 
within the cell monolayer. 
(B) The quantitation of 
osteogenic differentiation 
was performed by deter-
mination of optical density 
of stained sample extracts. 
Data represent mean ± 
SEM (n=4). *p < 0.05 com-
pared with hBMSCs in OIM, #p < 0.05 compared with 
hBMSCs in OIM containing 
50 ng/ml BMP2.
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We measured changes in the expression levels of adipogenesis-related genes by real time 
PCR to confirm the effect of BMP2 on hADSCs. The induction of osteogenic differentiation in 
the presence of BMP2 increased expression of adipogenesis-related genes such as PPAR-γ 
isoform2 and CCAAT/enhancer binding protein-alpha (C/EBP-α) (Fig. 2C). 
To determine whether BMP2 adequately conveyed the hADSCs downstream signal, we 
first determined expression of BMP2 receptors and BMP2 downstream genes in hADSCs. Real 
time PCR analyses showed that hADSCs expressed various BMP receptor isoforms and their 
expression level is similar with that of hBMSCs (Fig. 3A), and that a 2 day BMP2 treatment of 
hADSCs increased expression of distal-less homeobox 3 (DLX3) and inhibitor of DNA binding 
2 (ID2), well-known genes that are altered in response to BMP2 signaling (Fig. 3B). We next 
determined if BMP2 induces SMAD1 phosphorylation in hADSCs and hBMSCs. Western blot 
analysis showed that the 100 ng/ml BMP2 treatment induced SMAD1 phosphorylation in 
hADSCs as well as hBMSCs (Fig. 3C).
Fig. 2. The treatment of 
BMP2 shows variable effects 
on osteogenic differentiati-
on of hADSCs. (A) hADSCs 
were grown to confluence, 
and then osteogenic differen-
tiation was induced by OIM 
without or with BMP2. Os-
teogenic differentiation was 
determined by Alizarin Red 
S staining to visualize calcifi-
cation deposits within the cell 
monolayer. (Upper ; hADSCs 
from donor No 58 showing 
increased osteogenic diffe-
rentiation by BMP2, Lower 
; hADSCs from donor No 52 
showing decreased osteoge-
nic differentiation). (B) Lipid 
droplets formation was deter-
mined by Oil Red O staining. 
(C) Effect of BMP2 on adipo-
genesis-related genes expres-
sion in OIM. Total RNAs were 
isolated from hADSCs in CCM 
(Cont) or hADSCs at 3 days 
after treatment with or wit-
hout BMP2 in OIM, and then 
expression of adipogenesis 
related genes was analyzed 
by real time PCR. Experimen-
tal data were converted as the 
relative ratio to GUSB levels of 
the corresponding samples. 
Values were presented as fold 
change relative to the value of 
hADSCs in CCM (mean ± SEM, 
n=4). *p < 0.05 compared 
with hADSCs in CCM.
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Role of dexamethasone on BMP2-induced lipid droplet formation
Then, we determined whether dexamethasone was involved in BMP2-induced adipogenic 
differentiation. Omitting dexamethasone in OIM decreased basal osteogenic differentiation 
of hADSCs compared with OIM containing dexamethasone. BMP2 increased osteogenic 
differentiation in the absence of dexamethasone without inducing lipid droplet formation 
Fig. 3. Analysis of BMP2 downstream signal in hADSCs and hBMSCs. (A) Expression of BMP2 receptors in 
hADSCs and hBMSCs. Total RNA were isolated from hADSCs and hBMSCs. The expression of BMP receptors 
was analyzed by real time PCR. Data represent mean ± SEM of the relative ratio to β-actin levels of the corre-
sponding samples (n=8). (B) Effect of BMP2 on DLX3 and ID2 expression in hADSCs. Total RNA were isolated 
from hADSCs in CCM (Cont) or from hADSCs at 2 days after treatment of 100 ng/ml BMP2 in CCM. Gene 
expression was analyzed by real time PCR. Experimental data were converted as the relative ratio to GUSB 
levels of the corresponding samples. Values were presented as fold change relative to the value of hADSCs 
in CCM (mean ± SEM, n=3). *p < 0.05 compared with hADSCs in CCM. (C) Western blot analysis of SMAD1 
phosphorylation in hADSCs and hBMSCs. hADSCs or hBMSCs were treated for 0, 15 or 30 mins with 100 ng/
ml BMP2 in FBS-free CCM . Lysates were prepared at the indicated times and were subjected to immunoblot 
analysis using p-SMAD1, and total SMAD1 antibodies. To confirm equal loading of protein, the quantities of 
β-actin were determined by anti-β-actin antibody.
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in hADSCs. However, the level of osteogenic differentiation was similar with differentiation 
in control hADSCs in OIM containing dexamethasone (Fig. 4A and B). We observed that 
increased cell number during osteogenic differentiation in the absence of dexamethasone 
resulted in curling up of hADSCs. Therefore, we determined the effect of dexamethasone 
on hADSCs proliferation. Adding 0.1 μM dexamethasone to the control culture medium 
(CCM) at a concentration that induced osteogenesis inhibited cell proliferation. OIM without 
dexamethasone significantly increased cell number compared with that in CCM and in the 
OIM containing dexamethasone (Fig. 4C). 
To further confirm whether dexamethasone is necessary for BMP2-induced adipogenic 
differentiation, we determined the effect of BMP2 in the presence of dexamethasone in 
CCM. Dexamethasone alone did not induce the formation of lipid droplets. Adding 100 
ng/ml BMP2 with dexamethasone increased the formation of lipid droplets of hADSCs in 
CCM (Fig. 5A). Real time PCR analysis showed that adding dexamethasone increased C/
EBP-α and PPAR-γ isoform2 expression in hADSCs. Adding BMP2 further increased C/EBP-α 
expression but not PPAR-γ isoform2 expression in hADSCs (Fig. 5B). 
Fig. 4. BMP2 enhance osteogenic differentiation of hADSCs in the absence of dexamethasone. (A) hADSCs 
were grown to confluence, and then osteogenic differentiation in the absence or presence of 100 ng/ml 
BMP2 was induced in OIM containing 0.1 µM dexamethasone or OIM in which dexamethasone was omit-
ted. Osteogenic differentiation was determined by Alizarin Red S staining to visualize calcification deposits 
within the cell monolayer. (B) The quantitation of osteogenic differentiation was performed by the determi-
nation of optical density of stained sample extract. Data represent mean ± SEM (n=4). *p < 0.05 compared 
with OIM, #p < 0.05 compared with OIM w/o dexamethasone. (C) Effect of dexamethasone on hADSCs proli-
feration. Proliferation of hADSCs was determined by direct cell counting with a hemocytometer at 1-6 days 
after plating cells in CCM or OIM in the absence or presence of 0.1 μM dexamethasone. Data represent mean 
± SEM. *p < 0.05, CCM w/ dexamethasone vs CCM w/o dexamethasone (n=4), #p < 0.05, OIM vs OIM w/o 
dexamethasone (n=4), †p < 0.05, OIM w/o dexamethasone vs CCM w/o dexamethasone (n=4).
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TNF-α on BMP2 action in hADSCs 
To determine whether inhibiting BMP2-induced adipogenesis in hADSCs under 
osteogenic conditions increased osteogenic differentiation of hADSCs in the presence of 
BMP2, we determined the effect of TNF-α treatment. Previous studies have shown that 
TNF-α increases osteogenic differentiation [21] and inhibits adipogenic differentiation of 
hADSCs [22]. Treatment with 10 ng/ml TNF-α in OIM increased osteogenic differentiation in 
hADSCs, and BMP2 inhibited osteogenic differentiation and induced lipid droplet formation. 
The combined treatment of TNF-α and BMP2 further increased osteogenic differentiation 
compared with TNF-α alone (which was determined by measurement in the optical density 
of Alizalin Red S staining and calcium deposition amount), and inhibited BMP2-induced 
adipogenic differentiation (Fig. 6A-D). Real time PCR analysis showed that TNF-α treatment 
inhibited BMP2-induced C/EBP-α expression and dexamethasone-induced PPAR-γ isoform2 
expression (Fig. 6E). 
Discussion
In this study we found that BMP2 inhibits osteogenic differentiation in hADSCs isolated 
from most donors (6/8). To elucidate underlying mechanisms of donor variation, further 
Fig. 5. BMP2 induces lipid droplet formation in the presence of dexamethasone alone. (A) BMP2 (100 
ng/ml) was treated for 10 days in CCM in the absence or presence of 0.1 μM dexamethasone. Lipid droplets 
formation was determined by Oil Red O staining. (B) Effect of BMP2 and dexamethasone on adipogenesis-
related transcription factors. Total RNA were isolated from hADSCs in CCM (cont) or hADSCs at 3 days after 
plated in CCM containing dexamethasone, BMP2 or both. Experimental data were converted as the relative 
ratio to GUSB levels of the corresponding samples. Values were presented as fold change relative to the value 
of hADSCs in CCM (mean ± SEM, n=4). *p < 0.05 compared with hADSCs in CCM, #p < 0.05 compared with 
hADSCs in CCM containing dexamethasone.
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Fig. 6. Effect of TNF-α on BMP2-
induced differentiation of hADSCs. 
(A-C) hADSCs were grown to conflu-
ence, and then induced osteogenic 
differentiation by OIM containing 
10 ng/ml TNF-α, 100 ng/ml BMP2 
or its combination. (A) Osteogenic 
differentiation was evaluated by 
Alizarin Red S staining to visualize 
calcification deposits within the cell 
monolayer. (B) The quantitation of 
osteogenic differentiation was per-
formed by determination of optical 
density of stained sample extract. 
Data represent mean ± SEM (n=4). 
Osteogenic differentiation was indu-
ced in OIM (Cont) or OIM containing 
BMP2, TNF-α, or both for 14 days. 
*p < 0.05 compared with hADSCs in 
OIM (Cont), #p < 0.05 compared with 
hADSCs in OIM containing TNF-α. (C) 
Determination of calcium deposition 
in hADSCs at day 14 after induction 
of differentiation. Data represent 
mean ± SEM (n =4). *p < 0.05 com-
pared with hADSCs in OIM (Cont), #p < 0.05 compared with hADSCs in 
OIM containing TNF-α. (D) Effect of 
TNF-α on BMP2-induced adipogenic 
differentiation of hADSCs in OIM. Li-
pid droplet formation was determi-
ned by Oil Red O staining. (E) Effect 
of TNF-α on BMP2-induced changes 
in C/EBP-α or PPAR-γ isoform2 ex-
pression. Gene expression was ana-
lyzed by Real time PCR Total RNA 
were isolated from hADSCs in CCM 
(Cont) or from hADSCs at 3 days af-
ter treatment of BMP2 or TNF-α or 
its combination in CCM with or wi-
thout 0.1 μM dexamethasone. Expe-
rimental data were converted as the 
relative ratio to GUSB levels of the 
corresponding samples. Values were 
presented as fold change relative to 
the value of hADSCs in CCM (mean ± 
SEM, n=4). *p < 0.05 compared with 
hADSCs in CCM, #p < 0.05 compa-
red with hADSCs in CCM containing 
dexamethasone and BMP2. 
investigations including variation of epigenetic status and expression profile of genes that 
are involved in BMP2 signaling and in osteogenic and adipogenic differentiation are required.
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The in vitro differentiation study and real time PCR analysis of lineage-related genes 
showed that BMP2 induced adipogenic differentiation in the presence of dexamethasone even 
under osteogenic conditions in all hADSCs to be examined in this study, although there is a 
donor variation in the BMP2 action on osteogenic differentiation. Zuk et al. reported a defect 
of BMP2 signaling in hADSCs [13]. However, we observed expression of various isoforms of 
BMP receptors and increase in expression of BMP2 downstream target genes such as DLX3 
and ID2 [23] as like in hBMSCs. BMPs binding induces formation of heteromultimers of both 
type I and II receptors [24]. Activated BMP type I receptors phosphorylate their downstream 
targets SMAD1, SMAD5, and SMAD8 proteins, which interact with SMAD4 and translocate 
to the nucleus [25]. We observed BMP2-induced SMAD1 phosphorylation in hADSCs as well 
as hBMSCs. All of these findings indicate preservation of intact BMP2 signaling pathways in 
hADSCs.
PPAR-γ and the CCAAT/enhancer-binding protein (C/EBP) family regulate adipocyte 
differentiation. C/EBP-β and C/EBP-δ are expressed early during adipogenesis [26, 27] and 
are involved in the induction of PPAR expression [28, 29]. The overlap between PPAR-γ and 
C/EBP-α binding indicates cooperativity between the two transcription factors [30, 31]. 
In this study, the treatment of dexamethasone alone did not induce the formation of lipid 
droplets in hADSCs in spite of the increase of PPAR-γ isoform2 and C/EBP-α expression. The 
addition of BMP2 induced further increase of C/EBP-α expression and formed lipid droplets. 
These data suggest that the later stage of adipose differentiation may require an adequate 
level of C/EBP-α expression in hADSCs. 
We showed that dexamethasone is an essential component of the BMP2-induced increase 
in adipogenic differentiation in OIM, demonstrating that adding dexamethasone alone in 
CCM is sufficient for BMP2-induced adipogenesis. Although the presence of dexamethasone 
inhibited BMP2-induced osteogenic action in most hADSCs, the removal of dexamethasone 
inhibited osteogenic differentiation in hADSCs, indicating that dexamethasone is necessary 
to support osteogenic differentiation of hADSCs in the absence of BMP2 (100 ng/ml). 
Dexamethasone (0.1 µM) was sufficient at inhibiting hADSCs proliferation in control and 
OIM, and the presence of dexamethasone in OIM showed better osteogenic differentiation in 
hADSCs than that in OIM in which dexamethasone was omitted. Therefore, the inhibited cell 
proliferation and the increase of mineralization by glucocorticoids [32, 33] could be related 
to the dexamethasone-induced increase in osteogenic differentiation of hADSCs. 
In this study, treatment of TNF-α inhibited BMP2-induced formation of lipid droplets, 
and PPAR-γ and C/EBP-α expression. These results are consistent with the previous findings 
that TNF-α inhibits adipogenic differentiation through the inhibition of PPAR-γ and C/EBP-α 
expression in murine cells [34, 35]. PPAR-γ plays a critical role in commitment switch of 
progenitor cells between adipogenesis and osteogenesis [36, 37]. It has been reported that 
PPAR-γ silencing increases osteogenic differentiation of hADSCs [38]. We observed that 
the treatment of TNF-α restored the BMP2-induced increase in osteogenic differentiation 
in hADSCs in which the addition of BMP2 alone inhibited osteogenic differentiation, which 
results from TNF-α-induced inhibition of PPAR-γ and C/EBP-α expression. ADSCs have been 
shown to be inferior to BMSCs in osteogenic potential [7, 39]. Osteogenically predifferentiated 
BMSCs showed better in vivo bone regeneration than undifferentiated BMSCs [40] and 
chondrogenic preinduction enhanced bone regeneration of ADSCs transplantation [39]. 
Therefore, the findings in this study indicated that the combined pretreatment of TNF-α and 
BMP2 may enhance the efficacy of in vivo bone regeneration by hADSCs transplantation. 
In this study, we elucidated the BMP2 action on osteogenic differentiation of hADSCs. 
The results of our current study show that treatment of TNF-α inhibited of BMP2-induced 
lipid droplet formation at the osteogenic condition and restored BMP2-induced increase of 
osteogenic differentiation in hADSCs in which the addition of BMP2 alone inhibited osteogenic 
differentiation, indicating that osteogenesis and adipogenesis in hADSCs is closely regulated. 
These findings contribute to develop efficient methods of hADSCs manipulation for in vivo 
bone regeneration using BMP2. 
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